AMX vs. VRTX
Compare and contrast key facts about América Móvil, S.A.B. de C.V. (AMX) and Vertex Pharmaceuticals Incorporated (VRTX).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: AMX or VRTX.
Correlation
The correlation between AMX and VRTX is 0.26, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
AMX vs. VRTX - Performance Comparison
Key characteristics
AMX:
-0.84
VRTX:
-0.04
AMX:
-1.08
VRTX:
0.11
AMX:
0.88
VRTX:
1.02
AMX:
-0.59
VRTX:
-0.04
AMX:
-1.46
VRTX:
-0.11
AMX:
14.58%
VRTX:
7.68%
AMX:
25.35%
VRTX:
24.51%
AMX:
-64.34%
VRTX:
-91.77%
AMX:
-36.20%
VRTX:
-21.22%
Fundamentals
AMX:
$44.15B
VRTX:
$103.71B
AMX:
$0.58
VRTX:
-$1.89
AMX:
1.24
VRTX:
1.06
AMX:
$632.28B
VRTX:
$8.09B
AMX:
$393.74B
VRTX:
$6.99B
AMX:
$205.29B
VRTX:
-$699.50M
Returns By Period
In the year-to-date period, AMX achieves a -2.73% return, which is significantly lower than VRTX's 1.10% return. Over the past 10 years, AMX has underperformed VRTX with an annualized return of -1.02%, while VRTX has yielded a comparatively higher 13.28% annualized return.
AMX
-2.73%
-7.69%
-17.40%
-21.12%
-0.04%
-1.02%
VRTX
1.10%
-12.26%
-14.21%
-2.17%
13.33%
13.28%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
AMX vs. VRTX - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for América Móvil, S.A.B. de C.V. (AMX) and Vertex Pharmaceuticals Incorporated (VRTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
AMX vs. VRTX - Dividend Comparison
AMX's dividend yield for the trailing twelve months is around 3.63%, while VRTX has not paid dividends to shareholders.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
AMX América Móvil, S.A.B. de C.V. | 3.63% | 3.53% | 120.36% | 4.00% | 1.88% | 2.42% | 2.29% | 2.30% | 1.91% | 3.39% | 8.96% | 1.63% |
VRTX Vertex Pharmaceuticals Incorporated | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
AMX vs. VRTX - Drawdown Comparison
The maximum AMX drawdown since its inception was -64.34%, smaller than the maximum VRTX drawdown of -91.77%. Use the drawdown chart below to compare losses from any high point for AMX and VRTX. For additional features, visit the drawdowns tool.
Volatility
AMX vs. VRTX - Volatility Comparison
The current volatility for América Móvil, S.A.B. de C.V. (AMX) is 8.62%, while Vertex Pharmaceuticals Incorporated (VRTX) has a volatility of 13.98%. This indicates that AMX experiences smaller price fluctuations and is considered to be less risky than VRTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
AMX vs. VRTX - Financials Comparison
This section allows you to compare key financial metrics between América Móvil, S.A.B. de C.V. and Vertex Pharmaceuticals Incorporated. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities